Search

everythinglearnresearchcommunity

for

Search:↓

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Blocking JAK-STAT signaling can lead to hair growth.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Baricitinib can cause excessive hair growth.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

The hydrogel improves hair growth treatment by enhancing drug delivery and promoting follicle repair.

Glyoxylic acid straighteners cause more protein loss but have similar hair strength effects as traditional alkaline straighteners.

A postmenopausal woman's masculine symptoms improved after surgery for a hormone-producing ovarian tumor.

Enzyme replacement therapy may help alleviate symptoms in complex cases like this.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

SSO helps in skin protection and keratinization.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Hydroxyl radicals cause hair follicle cell death during chemotherapy by reducing Bcl-2 protein levels.

Some drugs can cause hair loss and skin issues.

Tranilast successfully treated a man's skin sarcoidosis when other treatments failed.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Abrocitinib effectively treats severe alopecia areata with significant improvement and no side effects.

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

GLP-1 agonists may help treat certain skin conditions.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

LHTric-1 is a specific antibody useful for studying hair and nail formation.